еш Контролирани клинични проучвания при диабет тип 1 или тип 2 са показали, че EXUBERA
Controlled clinical trials in type 1 or type 2 diabetes have shown that EXUBERA achieves and maintains effective glycaemic control comparable to subcutaneously administered fast-acting human insulin.